Earnings · China A-shares
Landfar Bio-medicine Co., Ltd. Class A (000504) earnings
Landfar Bio-medicine Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -143.00% year on year, -1310.43% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -7.17% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -143.00%
- Excl. one-offs YoY
- -1310.43%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.36% | — |
| 3 days | -7.17% | — |
| 7 days | -1.31% | — |
| 14 days | -8.60% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -1.62%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥2.25M | -143.00% | — | +398.86% | -0.01 | -0.85% | -7.17% | — | — |
| 2026 interim report | 2026-08-24 | ¥5.99M | +271.99% | +164.86% | +473.56% | 0.02 | 2.23% | -2.37% | +34.64% | +41.55% |
| 2026 Q1 report | 2026-04-29 | ¥11.10M | +600.34% | +399.05% | +431.32% | 0.03 | 4.09% | -5.64% | -16.50% | -17.44% |
| 2025 annual report | 2026-04-29 | ¥28.83M | +245.26% | +136.62% | +209.37% | 0.09 | 11.46% | -5.64% | -16.50% | -17.44% |
| 2025 Q3 report | 2025-10-27 | ¥5.23M | +162.21% | +103.00% | -9.72% | 0.02 | 2.18% | -2.65% | -3.60% | -3.37% |
| 2025 interim report | 2025-08-28 | -¥3.48M | +58.48% | +40.55% | -8.40% | -0.01 | -1.48% | +2.66% | -1.88% | -7.38% |
| 2025 Q1 report | 2025-04-29 | -¥2.22M | +19.92% | +9.77% | -13.55% | -0.01 | -0.94% | +5.42% | +53.15% | +50.57% |
| 2024 annual report | 2025-04-29 | -¥19.85M | +29.56% | +31.20% | -1.71% | -0.06 | -8.03% | +5.42% | +53.15% | +50.57% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.